NIH Guide for Grants and Contracts
March 20, 2020
Weekly NIH Funding Opportunities and Notices

General Notices

Notice of Changes to Funding Opportunities

Notices of Intent to Publish

Notices of Special Interest

  • Notice of Special Interest (NOSI): Competitive Revisions for Firearms Injury and Mortality Prevention Research
    (NOT-OD-20-089)
    Office of Behavioral and Social Sciences Research
    National Center for Complementary and Integrative Health
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute of Mental Health
    National Institute on Minority Health and Health Disparities
    Office of Disease Prevention
    Office of Research on Women's Health

Funding Opportunities

  • Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional)
    (PA-20-141)
    National Institute of Mental Health
    Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below

  • Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
    (PA-20-142)
    National Institutes of Health
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Eye Institute
    National Human Genome Research Institute
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Environmental Health Sciences
    National Institute of General Medical Sciences
    National Institute of Mental Health
    National Institute of Nursing Research
    Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
    Application Receipt Date(s): Standard dates apply All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Center of Excellence for Research on Complementary and Integrative Health (P01,Clinical Trial Optional)
    (PAR-20-138)
    National Center for Complementary and Integrative Health
    Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is May 25, 2020. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
    (PAR-20-140)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): Standard dates apply.

  • Firearm Injury and Mortality Prevention Research (R61 Clinical Trial Optional)
    (PAR-20-143)
    Office of Behavioral and Social Sciences Research
    National Center for Complementary and Integrative Health
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute on Minority Health and Health Disparities
    Office of Disease Prevention
    Office of Research on Women's Health
    Application Receipt Date(s): May 15, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional)
    (RFA-CA-20-027)
    National Cancer Institute
    Application Receipt Date(s): July 31, 2020; July 30, 2021

  • Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional)
    (RFA-CA-20-028)
    National Cancer Institute
    Application Receipt Date(s): July 31, 2020; July 30, 2021

  • Patient-oriented Research to Mitigate Health Disparities and Lessen the Burden of Chronic Diseases Within the Mission of NIDDK (R01 Clinical Trial Optional)
    (RFA-DK-20-015)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): May 22, 2020 No late applications will be accepted for this Funding Opportunity Announcement.

  • Genomic Predictors of Pregnancy Loss (R01 Clinical Trial Not Allowed)
    (RFA-HD-21-005)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Human Genome Research Institute
    Application Receipt Date(s): July 30, 2020

  • Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed)
    (RFA-HG-20-014)
    National Human Genome Research Institute
    Application Receipt Date(s): June 24, 2020; February 1, 2021; October 1, 2021; June 24, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Novel Synthetic Nucleic Acid Technology Development (R21 Clinical Trial not allowed)
    (RFA-HG-20-015)
    National Human Genome Research Institute
    Application Receipt Date(s): June 24, 2020; February 1, 2021; October 1, 2021; June 24, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Novel Synthetic Nucleic Acid Technology Development (R43/R44)( Clinical Trial not allowed)
    (RFA-HG-20-016)
    National Human Genome Research Institute
    National Center for Advancing Translational Sciences
    Application Receipt Date(s): June 24, 2020; February 1, 2021; October 1, 2021; June 24,2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.